Stearoyl-CoA desaturase-1 is associated with insulin resistance in morbidly obese subjects

Molecular Medicine

Volumn 17, Issue 3-4, 2011, Pages 273-280

  García Serrano, Sara ^a   Moreno Santos, Inmaculada ^b   Garrido Sánchez, Lourdes ^a   Gutierrez Repiso, Carolina ^b   García Almeida, Jose M ^c   García Arnés, Juan ^d   Rivas Marín, Jose ^c   Gallego Perales, Jose L ^d   García Escobar, Eva ^a   Rojo Martinez, Gemma ^a,b   Tinahones, Francisco ^a,c   Soriguer, Federico ^a,d   Macias Gonzalez, Manuel ^a,b   García Fuentes, Eduardo ^a,b,d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Hospital University Carlos Haya de Málaga   (Spain)

^c H Virgen de la Victoria   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE 1; ADENOSINE TRIPHOSPHATASE; BETA ACTIN; INSULIN; MESSENGER RNA; PROTEIN P97; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; MORBID OBESITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RNA ANALYSIS; SUBCUTANEOUS FAT;

ADENOSINE TRIPHOSPHATASES; ADIPOSE TISSUE; ADULT; AGED; ANIMALS; BLOTTING, WESTERN; FEMALE; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR PROTEINS; OBESITY, MORBID; PROTEIN ISOFORMS; RNA, MESSENGER; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SUBCUTANEOUS FAT;

EID: 79952827933     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00078     Document Type: Article

References (45)

1. Dobrzyn A, Ntambi JM. (2004) The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc. Med. 14:77-81.
2. Dobrzyn P, et al. (2004) Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc. Natl. Acad. Sci. U. S. A. 101:6409-14.
3. Cohen P, Ntambi JM, Friedman JM. (2003) Stearoyl-CoA desaturase-1 and the metabolic syndrome. Curr. Drug Targets Immune Endocr. Metabol. Disord. 3:271-80.
4. Soriguer F, et al. (2007) Obesity and the metabolic syndrome in Mediterranean countries: a hypothesis related to olive oil. Mol. Nutr. Food Res. 51:1260-7.
5. Ntambi JM, Miyazaki M. (2004) Regulation of stearoyl-CoA desaturase and role in metabolism. Prog. Lipid Res. 43:91-104.
6. Gaster M, Rustan AC, Beck-Nielsen H. (2005) Differential utilization of saturated palmitate and unsaturated oleate: evidence from cultured myotubes. Diabetes 54:648-56.
7. Ntambi JM, et al. (2002) Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. U. S. A. 99:11482-6.
8. Ntambi JM. (1999) Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 40:1549-58.
9. Rahman SM, et al. (2005) Stearoyl-CoA desaturase 1 deficiency increases insulin signaling and glycogen accumulation in brown adipose tissue. Am. J. Physiol. Endocrinol. Metab. 288:381-7.
10. Sjogren P, et al. (2008) Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Diabetologia 51:328-35.
11. Rahman SM, et al. (2003) Stearoyl-CoA desaturase 1 deficiency elevates insulin-signalling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc. Natl. Acad. Sci. U. S. A. 100:11110-5.
12. Flowers JB, et al. (2007) Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes 56:1228-39.
13. Collins JM, Neville MJ, Hoppa MB, Frayn KN. (2010) De novo lipogenesis and stearoyl-CoA desaturase are coordinately regulated in the human adipocyte and protect against palmitate-induced cell injury. J. Biol. Chem. 285:6044-52.
14. Sessler AM, Kaur N, Palta JP, Ntambi JM. (1996) Regulation of stearoyl-CoA desaturase 1 mRNA stability by polyunsaturated fatty acids in 3T3-L1 adipocytes. J. Biol. Chem. 271:29854-8.
15. Cohen P, et al. (2002) Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297:240-3.
16. Kato H, Sakaki K, Mihara K. (2006) Ubiquitinproteasome-dependent degradation of mammalian ER stearoyl-CoA desaturase. J. Cell Sci. 119:2342-53.
17. Carey AL, et al. (2006) Discordant gene expression in skeletal muscle and adipose tissue of patients with type 2 diabetes: effect of interleukin-6 infusion. Diabetologia 49:1000-7.
18. Dridi S, Taouis M, Gertler A, Decuypere E, Buyse J. (2007) The regulation of stearoyl-CoA desaturase gene expression is tissue specific in chickens. J. Endocrinol. 192:229-36.
19. Hulver MW, et al. (2005) Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab. 2:251-61.
20. Yao-Borengasser A, et al. (2008) Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness. J. Clin. Endocrinol. Metab. 93:4431-9.
21. Stefan N, et al. (2008) Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia 51:648-56.
22. Soriguer F, et al. (2008) Incidence of type 2 diabetes in southern Spain (Pizarra Study). Eur. J. Clin. Invest. 38:126-33.
23. Garcia-Fuentes E, et al. (2006) Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes. Surg. 16:1179-88.
24. Matthews DR, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 28:412-9.
25. Garcia-Fuentes E, et al. (2010) PPAR_ expression after a high-fat meal is associated with plasma superoxide dismutase activity in morbidly obese persons. Obesity (Silver Spring) 18:952-8.
26. Tinahones FJ, et al. (2010) Obesity and insulin resistance-related changes in the expression of lipogenic and lipolytic genes in morbidly obese subjects. Obes. Surg. 20:1559-67.
27. Soriguer F, et al. (2008) Changes in the serum composition of free-fatty acids during an intravenous glucose tolerance test. Obesity (Silver Spring) 17:10-5.
28. Soriguer F, Garcia-Serrano S, Garrido-Sanchez L, Gutierrez-Repiso C, Rojo-Martinez G, et al. (2010) Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus. J. Lipid Res. 51:3516-23.
29. Lappalainen T, et al. (2007) Adipose tissue stearoyl-CoA desaturase 1 (SCD1) gene expression in obese subjects. Int. J. Obes. 31:S46-77.
30. Mauvoisin D, Prevost M, Ducheix S, Arnaud MP, Mounier C. (2010) Key role of the ERK1/2 MAPK pathway in the transcriptional regulation of the stearoyl-CoA desaturase (SCD1) gene expression in response to leptin. Mol. Cell. Endocrinol. 319:116-28.
31. Kim YC, Gomez FE, Fox BG, Ntambi JM. (2000) Differential regulation of the stearoyl-CoA desaturase genes by thiazolidinediones in 3T3-L1 adipocytes. J. Lipid Res. 41:1310-6.
32. Rasouli N, Yao-Borengasser A, Miles LM, Elbein SC, Kern PA. (2006) Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am. J. Physiol. Endocrinol. Metab. 290:42-6.
33. Hojbjerre L, Rosenzweig M, Dela F, Bruun JM, Stallknecht B. (2007) Acute exercise increases adipose tissue interstitial adiponectin concentration in healthy overweight and lean subjects. Eur. J. Endocrinol. 157:613-23.
34. Heinemann FS, Ozols J. (2003) Stearoyl-CoA desaturase, a short-lived protein of endoplasmic reticulum with multiple control mechanisms. Prostaglandins Leukot. Essent. Fatty Acids 68:123-33.
35. Braun S, Matuschewski S, Rape M. (2002) Role of the ubiquitin-selective CDC48 (UFD1/NPL4) chaperone (segregase) in ERAD of OLE1 and other substrate. EMBO J. 21:615-21.
36. Medina-Gomez G, et al. (2007) PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism. PLoS Genet. 3:634-47.
37. Pinnamaneni SK, Southgate RJ, Febbraio MA, Watt MJ. (2006) Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acidinduced skeletal muscle insulin resistance in vitro. Diabetologia 49:3027-37.
38. Nolan CJ, Madiraju MS, Delghingaro-Augusto V, Peyot ML, Prentki M. (2006) Fatty acid signaling in the beta-cell and insulin secretion. Diabetes 55(Suppl. 2):S16-23.
39. Kraegen EW, Cooney GJ. (2008) Free fatty acids and skeletal muscle insulin resistance. Curr. Opin. Lipidol. 19:235-41.
40. Peter A, et al. (2009) Individual stearoyl-CoA desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes 58:1757-65.
41. Barbarroja N, et al. (2010) The obese healthy paradox: is inflammation the answer? Biochem. J. 430:141-9.
42. Stefan N, et al. (2008) Identification and characterization of metabolically benign obesity in humans. Arch. Intern. Med. 168:1609-16.
43. Marin P, et al. (1992) The morphology and metabolism of intra-abdominal adipose tissue in men. Metabolism 41:1241-8.
44. Hisra A, Vikram NK. (2003) Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 19:457-66.
45. Li Z, Berk M, McIntyre TM, Feldstein AE. (2009) Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl- CoA desaturase. J. Biol. Chem. 284:5637-44.